Methylprednisolone Sodium Succinate Injection, Powder, For Solution
Product Images NDC 72572-097

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 72572-097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Methylprednisolone Sodium Succinate For Injection 1)

Structure (Methylprednisolone Sodium Succinate For Injection  1)
Chemical structure diagram of Methylprednisolone Sodium Succinate showing its steroid backbone with various functional groups and the sodium succinate moiety attached.*
FDA Label Image

Vial Label (Methylprednisolone Sodium Succinate For Injection 2)

Vial Label (Methylprednisolone Sodium Succinate For Injection  2)
Label for Methylprednisolone Sodium Succinate for Injection, USP 40 mg per vial. Single-dose vial intended for intramuscular or intravenous use. The label includes reconstitution instructions, dosage information, storage directions, and identifies Civica, Inc. as the distributor and HIKMA FarmacĂȘutica (Portugal) as the manufacturer.*
FDA Label Image

Carton Label (Methylprednisolone Sodium Succinate For Injection 3)

Carton Label (Methylprednisolone Sodium Succinate For Injection  3)
Label for Methylprednisolone Sodium Succinate Injection, USP, 40 mg per vial. It is a powder for solution intended for intramuscular or intravenous use. The package contains 25 single-dose vials. The label notes use instructions including reconstitution with sterile water or bacteriostatic water with benzyl alcohol. The labeler is Civica, Inc.*
FDA Label Image

Vial Label (Methylprednisolone Sodium Succinate For Injection 4)

Vial Label (Methylprednisolone Sodium Succinate For Injection  4)
Label for Methylprednisolone Sodium Succinate injection, powder for solution, 125 mg per vial. The label indicates it is for intramuscular or intravenous use only and single-dose. The product is distributed by Civica, Inc. and contains instructions to reconstitute with 2 mL water for injection or bacteriostatic water. Additional distributor information from HIKMA FarmacĂȘutica is also present.*
FDA Label Image

Carton Label (Methylprednisolone Sodium Succinate For Injection 5)

Carton Label (Methylprednisolone Sodium Succinate For Injection  5)
Packaging label for Methylprednisolone Sodium Succinate for Injection, USP 125 mg per vial. The product is a powder for injection, intended for intramuscular or intravenous use. The label states the package contains 25 single-dose vials and is distributed by Civica, Inc. Additional instructions for reconstitution and storage are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.